INC Research provides the full range of Phase I to IV clinical development services. With its global scale and scope and broad therapeutic expertise, the company produces actionable data, enabling medicine providers to assess the potential of their products quickly and cost effectively while freeing resources to think develop new products. The company was acquired by Avista Capital in 2010, but still operates under the INC name.